India reshapes global public health with pandemic collaborations
With the latest rush of Covid vaccines worldwide, PM Modi has more than fulfilled the pledge to share India's expertise and resources in the global war against the virus.
Mauritius Based LTS Investment Fund Picks up Stake in Bliss GVS Pharma Ltd
As per Bulk deal data available on NSE, Mauritius based LTS Investment Fund has picked up stake in BSE and NSE listed Bliss GVS Pharma Ltd. Earlier, Life Corporation of India (LIC) had also raised stake in Bliss GVS Pharma.
How Covid-19 fast-tracked pharma innovation in India
Rollout of indigenous vaccines is a testament to how the Indian government, scientists and private investors have harnessed science to bring the pandemic to an end.
AstraZeneca’s signs MoU with Indian Diabetes Research Society (RSSDI) to empower 1 Crore Indian Diabetic patients by 2023
AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI).
Pharma firm in India to make Russia’s Sputnik V COVID-19 vaccine
Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia's RDIF sovereign wealth fund.
India to spend $27 billion over 5 years to boost manufacturing
India's cabinet approved a proposal to provide production-linked incentives of about 2 trillion rupees ($27 billion) over five years to create jobs and boost manufacturing in the country, the finance minister said.
Pharma, IT returns BSE,Sensex to pre-Covid heady days
Demand for a robust IT infrastructure and medicines ensures the positive phenomenon. Reliance secures another big cheque to keep the markets on their toes with the broader market keeping pace with frontline stocks.
Healthcare e-Compendium and Online CMEs an initiative of DPSRU and DRSC
Healthcare e-Compendium is the joint initiative of DPSRU (Delhi Pharmaceutical Sciences and Research University) and DRSC (Doctors' Resource and Science Centre for Continuing Education).
India’s pharma CMO sector a hotbed for private investors
Major investments by global private equity giants such as Advent, Carlyle and KKR in India’s contract manufacturing organization sector, amid the pandemic, reflect solid prospects for growth in the country’s complex generics and bulk drug manufacturers.
West Begins Warehousing Operations in Chennai, India
The warehouse in Sriperumbudur Chennai will serve customers within the Indian market and is integral to West's ongoing efforts to enhance the customer experience through shorter lead time and improved trading process.